News About: R&D
Multiple myeloma therapy, ‘Kyprolis’ conducted Phase 3 clinical trials on Koreans
The new multiple myeloma therapy, ‘Kyprolis(carfilzomib, Amgen),’ will start a Phase 3 clinical trial adding 16 Korean subjects.
It has attracted interests of the industry since it is a newly-approved clinical trial ...
Next-generation dementia therapy’s Phase 3 clinical trials starts in Korea
The next generation dementia therapy, which was expected to generate approximately KRW 1 trillion prescriptions in the global market, was approved to conduct Phase 3 clinical trials in Korea.
The therapy is ‘RVT-101’...
Celltrion starts global Phase 3 clinical trials on Remsima’s SC typeIn order to secure competitiveness in the TNF-α inhibitor(autoimmune disease therapy) market, Celltrion will start the global Phase 3 clinical trial of the Remsima’s SC type(sub... |
Arguments about Sanofi’s Menactra clinical trials for childrenSince Sanofi-Pasteur’s ‘Menactra,’ a competing product of the GSK’s top meningococcal meningitis vaccine in Korea, ‘Menveo,’ has been conducted for clinical trials to extend ind... |
Korea Drug Development Fund to conclude joint anticancer R&D agreement
The Korea Drug Development Fund(Head Sang-Un Joo, hereinafter referring to KDDF) will start the ‘BigPharma Joint R&D Program’ in regards of anticancer development researches.
On the 8th, the KDDF announced it conclu...
Osong & Daegu Medical Innovation Foundations’ cooperation with largest European BioCluster
On the 5th, Osong Medical Innovation Foundation(Chief Director Kyung Sun) and Daegu Gyeongbuk Medical Innovation Foundation(Chief Director Jae-tae Lee) announced conclusion of the Strategic Exploratory Agreement(SEA) ...
Extended tax deductions for new drug R&Ds
In order to foster new industries, the government decided to apply tax deduction even for expenses of Phase 3 clinical trials that are conducted in Korea.
Moreover, it also decided to raise the ‘New Industry Fosterin...
7 pharmaceutical companies to spend more than KRW 50 billion into R&D
Among listed pharmaceutical companies, there were 7 companies which invested more than KRW 50 billion into R&D expenses last year, including Hanmi Pharm and Green Cross.
Moreover, although many companies seem to acti...
Treatment spent the most R&D expenses, ‘tumor treatment’
A treatment spent the most R&D expenses by pharmaceutical companies was known to be tumor treatments.
The Korea Health Industry Development Institute recently unveiled the information through the ‘2014 Pharmaceutical...
Drug Research Association proposes ‘Expansion Of Target Technology For Tax Deduction On Pharmaceutical R&D Expenses’
The Korea Drug Research Association(Chairperson Dong-yeon Kim) submitted the ‘Opinions For The Review Of Technology Targeting Tax Deduction On New Growth Engine and Source Technology Research and Development’(Recommen...
Which are outstanding tetravalent vaccines even for the young?
Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer
Who will be the next Pharmaceutical Safety Bureau Director?
Celltrion completes clinical trials for Remsima SC for European approval
Sales listed pharmas made in the first half of the year
April
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
30 | 31 | 1 | 2 | 3 | 4 | 5 |
6 | 7 | 8 | 9 | 10 | 11 | 12 |
13 | 14 | 15 | 16 | 17 | 18 | 19 |
20 | 21 | 22 | 23 | 24 | 25 | 26 |
27 | 28 | 29 | 30 | 1 | 2 | 3 |
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
